Reynders McVeigh Capital Management LLC Has $23.37 Million Stock Position in AptarGroup, Inc. $ATR

Reynders McVeigh Capital Management LLC trimmed its holdings in shares of AptarGroup, Inc. (NYSE:ATR) by 40.6% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 186,679 shares of the industrial products company’s stock after selling 127,537 shares during the quarter. AptarGroup accounts for about 1.0% of Reynders McVeigh Capital Management LLC’s holdings, making the stock its 27th largest position. Reynders McVeigh Capital Management LLC’s holdings in AptarGroup were worth $23,372,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Geneos Wealth Management Inc. raised its holdings in shares of AptarGroup by 214.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 201 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 137 shares in the last quarter. Rothschild Investment LLC increased its position in shares of AptarGroup by 231.1% during the fourth quarter. Rothschild Investment LLC now owns 202 shares of the industrial products company’s stock valued at $25,000 after buying an additional 141 shares during the period. Silvant Capital Management LLC purchased a new stake in AptarGroup in the second quarter worth $30,000. Whittier Trust Co. lifted its holdings in shares of AptarGroup by 169.5% during the first quarter. Whittier Trust Co. now owns 283 shares of the industrial products company’s stock valued at $36,000 after purchasing an additional 178 shares during the last quarter. Finally, Parkside Financial Bank & Trust raised its position in shares of AptarGroup by 41.9% in the 2nd quarter. Parkside Financial Bank & Trust now owns 298 shares of the industrial products company’s stock worth $37,000 after purchasing an additional 88 shares during the last quarter. Institutional investors own 88.52% of the company’s stock.

Insider Activity at AptarGroup

In other AptarGroup news, insider Hedi Tlili sold 8,854 shares of the stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $135.00, for a total transaction of $1,195,290.00. Following the completion of the transaction, the insider owned 15,379 shares of the company’s stock, valued at $2,076,165. This represents a 36.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Stephan Tanda sold 9,838 shares of AptarGroup stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $136.16, for a total value of $1,339,542.08. Following the transaction, the chief executive officer owned 238,729 shares in the company, valued at approximately $32,505,340.64. The trade was a 3.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 23,197 shares of company stock valued at $3,134,828. 0.73% of the stock is currently owned by company insiders.

AptarGroup Stock Down 0.2%

Shares of ATR stock traded down $0.25 on Tuesday, hitting $124.66. The stock had a trading volume of 474,728 shares, compared to its average volume of 493,782. The company has a market cap of $7.93 billion, a PE ratio of 22.54, a P/E/G ratio of 3.19 and a beta of 0.38. The company has a quick ratio of 1.10, a current ratio of 1.61 and a debt-to-equity ratio of 0.42. AptarGroup, Inc. has a one year low of $103.23 and a one year high of $146.91. The business has a 50 day moving average price of $131.05 and a 200 day moving average price of $126.60.

AptarGroup (NYSE:ATR) last announced its earnings results on Thursday, July 30th. The industrial products company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.35 by $0.07. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.01 billion. AptarGroup had a net margin of 9.22% and a return on equity of 13.31%. AptarGroup’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm earned $1.66 earnings per share. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS. Research analysts anticipate that AptarGroup, Inc. will post 5.48 earnings per share for the current fiscal year.

AptarGroup Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 20th. Shareholders of record on Thursday, July 30th were given a dividend of $0.48 per share. The ex-dividend date was Thursday, July 30th. This represents a $1.92 dividend on an annualized basis and a yield of 1.5%. AptarGroup’s dividend payout ratio is currently 34.72%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on ATR shares. Bank of America raised shares of AptarGroup from a “neutral” rating to a “buy” rating and set a $173.00 target price for the company in a research report on Tuesday, July 14th. Weiss Ratings restated a “hold (c)” rating on shares of AptarGroup in a research report on Wednesday, June 24th. Raymond James Financial restated an “outperform” rating and set a $160.00 target price on shares of AptarGroup in a research report on Wednesday, July 15th. Finally, Wells Fargo & Company increased their price target on shares of AptarGroup from $145.00 to $155.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Five analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $172.80.

AptarGroup Company Profile

AptarGroup, Inc is a global supplier of dispensing, packaging and drug-delivery solutions. The company develops and manufactures pumps, valves, aerosol systems, closures, dispensing devices and other components used to package and deliver products in the pharmaceutical, beauty, personal care, food and beverage markets.

Its pharmaceutical offerings include nasal, respiratory, ophthalmic and dermal drug-delivery systems, as well as components and technologies designed to support the administration of prescription and consumer healthcare products.